Recent growth in the biopharmaceutical industry in both China, and India suggest a future positive outlook for contract manufacturing in both regions.
Thursday, February 05, 2015
Although relatively few biosimilar products have entered major markets, including no approvals yet in the US, this new class of biopharmaceuticals
is already having a major impact on many (bio)pharmaceutical contract manufacturing organizations (...